Les présentations de Theratechnologies lors de l’IDWeek mettent en évidence l’incidence de l’excès de graisse viscérale abdominale sur le risque de maladie cardiovasculaire chez les personnes vivant avec le VIH
17 oct. 2024 14h00 HE
|
Theratechnologies
MONTRÉAL, 17 oct. 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une entreprise biopharmaceutique axée sur la mise au...
Theratechnologies IDWeek Presentations Highlight the Impact of Excess Visceral Abdominal Fat (EVAF) on Cardiovascular Disease (CVD) Risk in People with HIV
17 oct. 2024 14h00 HE
|
Theratechnologies
MONTREAL, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on development and...
Autologous Cell Therapy Market Estimated to Grow USD 34.7 Billion by 2027, Rising at a 18.1% CAGR- Transparency Market Research, Inc.
21 août 2024 11h09 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. , Aug. 21, 2024 (GLOBE NEWSWIRE) -- According to Transparency Market Research (TMR), the global autologous cell therapy market...
Acclaimed Cardiology Expert Dr. Peter Libby To Keynote 19th Annual CMHC, Revolutionize Atherosclerosis Care
22 mai 2024 11h00 HE
|
Cardiometabolic Health Congress
Boca Raton, FL, May 22, 2024 (GLOBE NEWSWIRE) -- The Cardiometabolic Health Congress (CMHC) is proud to announce that one of the foremost authorities in atherosclerosis, Peter Libby, MD, will...
Verve Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results
07 nov. 2023 06h30 HE
|
Verve Therapeutics
U.S. Food and Drug Administration (FDA) Clears Investigational New Drug Application for VERVE-101 in Patients with Heterozygous Familial Hypercholesterolemia (HeFH) Collaboration with Eli Lilly and...
MSP Unveils Turbo II™ Vaporizers
06 nov. 2023 12h25 HE
|
MSP, a Division of TSI
Shoreview, MN, Nov. 06, 2023 (GLOBE NEWSWIRE) -- MSP, a Division of TSI®, is thrilled to announce the launch of the new line of MSP Turbo II™ Vaporizers. Engineered for chemical vapor deposition...
Verve and Lilly Relationship Expands to Include Verve’s In Vivo Gene Editing Programs Targeting PCSK9 and ANGPTL3
31 oct. 2023 06h01 HE
|
Verve Therapeutics
BOSTON, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Verve Therapeutics, Inc., a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene...
Transdermal Drug Delivery System Market to Hit 4.3% CAGR with Transdermal Gels Segment Driving Growth During 2022–2030 | The Insight Partners
25 oct. 2023 10h40 HE
|
The Insight Partners
Pune, India, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Transdermal drug delivery systems are dosage forms actively used to deliver a therapeutically effective amount of drug across a patient’s skin. It is a...
Cardiovascular Digital Solutions Market to Reach $154.1 Billion, by 2032 at 6.2% CAGR: Allied Market Research
04 sept. 2023 08h38 HE
|
Allied Market Research
New Castle, Delaware, Sept. 04, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Cardiovascular Digital Solutions Market by Service (Unobtrusive Monitoring, CVD Health...
Chemical Vapor Deposition Global Market Report 2023: Growth in Solar and Photovoltaic Cells Drives $40 Billion Industry
12 avr. 2023 08h13 HE
|
Research and Markets
Dublin, April 12, 2023 (GLOBE NEWSWIRE) -- The "Chemical Vapor Deposition Market Size, Share & Trends Analysis Report By Category (CVD Equipment), By Application (Semiconductor &...